Wakefit Innovations alters MOA after shareholder approval

1 min read     Updated on 08 Jun 2026, 05:14 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Wakefit Innovations Limited secured shareholder approval to alter its Memorandum of Association (MOA) by amending existing object clauses and including new ones. The special resolution was passed through a remote e-voting process, with the approval deemed received on June 6, 2026. The resolution received overwhelming support, with 310,304,613 votes, or 99.9994% of the votes polled, cast in favour.

powered bylight_fuzz_icon
42300285

*this image is generated using AI for illustrative purposes only.

Wakefit Innovations Limited has secured shareholder approval to alter its Memorandum of Association (MOA) by amending existing object clauses and including new ones. The special resolution was passed through a remote e-voting process, with the approval deemed received on June 6, 2026. This alteration allows the company to expand its operational scope as defined in its constitutional documents.

The postal ballot was conducted pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 110 of the Companies Act, 2013. BMP & Co. LLP, Practicing Company Secretaries, served as the scrutinizer for the process. The remote e-voting period commenced at 9:00 a.m. IST on May 8, 2026, and concluded at 5:00 p.m. IST on June 6, 2026.

A total of 310,306,213 votes were polled, representing 94.0416% of the total outstanding shares. The resolution received overwhelming support, with 310,304,613 votes, or 99.9994% of the votes polled, cast in favour. Only 1,600 votes were cast against the resolution. There were no invalid votes or abstentions recorded during the process.

Voting Breakdown

The following table details the voting results by shareholder category:

Category Shares Held Votes Polled Votes in Favour Votes Against % in Favour
Promoter and Promoter Group 122,189,371 122,189,371 122,189,371 0 100.0000
Public Institutions 188,585,262 178,003,263 178,003,263 0 100.0000
Public Non-Institutions 19,192,116 10,113,579 10,111,979 1,600 99.9841
Total 329,966,749 310,306,213 310,304,613 1,600 99.9994

The scrutinizer's report confirmed that the resolution was passed with the requisite majority. The results were disclosed to the stock exchanges and made available on the company's website. Surbhi Sharma, Company Secretary and Compliance Officer for Wakefit Innovations Limited, signed off on the results.

Historical Stock Returns for Wakefit Innovations

1 Day5 Days1 Month6 Months1 Year5 Years
+4.41%-2.27%-7.65%-38.62%-38.62%-38.62%

What specific new business lines or markets does Wakefit plan to enter with this expanded operational scope?

How will the company fund the expansion initiatives enabled by these new object clauses?

Will this strategic shift impact Wakefit's core profitability or require significant changes in capital allocation?

Wakefit grants 3.28 lakh ESOPs at Re 1

1 min read     Updated on 25 May 2026, 10:53 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Wakefit Innovations granted 3,28,342 Employee Stock Options under its 2019 plan, approved by the Nomination and Remuneration Committee on May 23, 2026. The options, exercisable into equity shares with a face value of Re. 1, have an exercise price of Re. 1. Vesting begins after 12 months and extends up to 5 years, subject to performance and continued service.

powered bylight_fuzz_icon
40943047

*this image is generated using AI for illustrative purposes only.

Wakefit Innovations has granted 3,28,342 Employee Stock Options under its Wakefit Employee Stock Option Plan - 2019 (ESOP 2019). The grant was approved by the company's Nomination and Remuneration Committee on May 23, 2026, in compliance with SEBI regulations.

Grant Details

The options are exercisable into 3,28,342 equity shares, each with a face value of Re. 1. The exercise price has been determined at Re. 1 per option. The vesting for these options will commence after a minimum period of 12 months from the grant date and will not extend beyond 5 years. Vesting is contingent upon time and performance criteria, subject to the employee's continued service with the organization.

Key Terms

The following table outlines the specific details of the grant:

Particulars Details
Options Granted 3,28,342
Exercise Price Re. 1 per Option
Vesting Period 12 months to 5 years
Exercise Window 1 year from vesting date

All vested options must be exercised within a maximum period of one year from the date of vesting. The company noted that the vesting timelines may be extended for employees on unauthorized or non-statutory leaves as per the ESOP Plan provisions.

Historical Stock Returns for Wakefit Innovations

1 Day5 Days1 Month6 Months1 Year5 Years
+4.41%-2.27%-7.65%-38.62%-38.62%-38.62%

How will this ESOP grant impact Wakefit's employee retention and talent acquisition strategy in the competitive sleep-tech market?

What are the potential implications for Wakefit's equity dilution and shareholder value as these options vest over the next five years?

Could this move signal Wakefit's preparations for an IPO or a significant funding round in the near future?

More News on Wakefit Innovations

1 Year Returns:-38.62%